Previous Section | Index | Home Page |
Mr. Andrew Turner: To ask the Secretary of State for International Development (1) if she will list those public bodies which are the responsibility of her Department and which are not listed in Public Bodies 2000; [17598]
(3) if she will list those local bodies which were set up under legislation which is the responsibility of her Department since May 1997. [17599]
Chris McCafferty: To ask the Secretary of State for International Development if she will list her Department's individual aid contributions to international sexual and reproductive health NGOs via the Civil Society Challenge Fund in (a) 1997, (b) 1998, (c) 1999, (d) 2000, (e) 2001 and the projected contributions for (f) 2002, (g) 2003 and (h) 2004. [16645]
Clare Short: The levels of funding granted by my Department to international sexual and reproductive health NGOs under the Civil Society Challenge Fund, since the introduction of the scheme in 200001 is as follows.
23 Nov 2001 : Column: 492W
£000 | |
---|---|
200001 | |
Population Services International | 78 |
200102 | |
International Family Health | 152 |
Population Services International | 240 |
200203 | |
International Family Health | 142 |
Population Services International | 257 |
200304 | |
International Family Health | 81 |
Population Services International | 78 |
200405 | |
International Family Health | 12 |
The funding indicated for 200203 onwards represents projects to which we are already committed. Further funding will be dependent on the success of new Civil Society Challenge Fund applications.
Chris McCafferty: To ask the Secretary of State for International Development (1) if she will list her Department's sexual and reproductive health aid contribution, actual and as a percentage of GNP, for (a) 1997, (b) 1998, (c) 1999, (d) 2000, (e) 2001 and projected contributions for the years (f) 2002, (g) 2003, and (h) 2004 broken down into (i) bilateral, (ii) EU, (iii) multilateral and (iv) NGO aid contributions (A) in total and (B) as a proportion of GNP; [16546]
(3) if she will list her Department's bilateral aid contributions to sexual and reproductive health aid for (a) 1997, (b) 1998, (c) 1999, (d) 2000, (e) 2001 and projected contributions for the years (f) 2002, (g) 2003 and (h) 2004, broken down by country. [16547]
Clare Short: Information in the appropriate format has been collected centrally only since 1 April 1998.
In the last three fiscal years, DFID committed the following amounts to projects aimed at Reproductive Health Services including HIV/AIDS.
Year | £ million |
---|---|
199899 | 39 |
19992000 | 202 |
200001 | 436 |
A breakdown of these figures by country has been placed in the Library of the House. It is not appropriate to present these figures as a proportion of GNP. Contributions for future years are not available.
In addition to the figures shown in the table, over the same period, DFID made total multilateral contributions to UNFPA of £79.5 million, UNAIDS of £12 million, IPPF of £21 million and WHO-HRP of £0.3 million for activities related to reproductive health services including HIV/AIDS.
23 Nov 2001 : Column: 493W
Chris McCafferty: To ask the Secretary of State for International Development if she will list her Department's individual aid contributions to international sexual and reproductive health NGOs in (a) 1997, (b) 1998, (c) 1999, (d) 2000, (e) 2001 and the projected contributions for (f) 2002, (g) 2003 and (h) 2004. [16646]
Clare Short: Figures on DFID's aid contribution for the last five fiscal years are available in "Statistics on International Development 199697 to 200101" a copy of which is posted on DFID's website at the following address www.dfid.gov.uk/. The tables which are of relevance are "Table 13 DFID Programme : Bilateral Grants and Other Aid in Kind and Table 14 DFID Expenditure through UK CSOs 200001". It is not appropriate to provide projected contributions for future years. A printed version of "Statistics on International Development (SID)" will be placed in the Library of the House following its publication in late November.
Chris McCafferty: To ask the Secretary of State for International Development if she will list her Department's emergency relief aid contributions to sexual and reproductive health programme work for (a) 1997, (b) 1998, (c) 1999, (d) 2000, (e) 2001 and projected contributions for (f) 2002 (g) 2003 and (h) 2004. [16636]
Clare Short: This information is not collected centrally and to provide data on the basis requested would be at disproportionate cost.
Mrs. Spelman: To ask the Secretary of State for International Development what action she is taking to ensure that exports of refrigerators to the third world comply with the European regulations which come into effect on 1 January. [16247]
Clare Short: My Department applies Government policy on greening government operations and our procurement agents ensure that refrigerators purchased for use by the development programme comply with the new regulations.
Mr. Andrew Turner: To ask the Secretary of State for International Development how many employees of (a) her Department and (b) agencies sponsored by her Department work in (i) London, (ii) areas benefiting from EU objective 1 status, (iii) areas with objective 2 status and (iv) other areas. [16109]
Clare Short: (a) The numbers of staff employed by DFID in the United Kingdom as at 1 September 2001 were:
(b) There are no agencies sponsored by DFID.
Tony Worthington: To ask the Secretary of State for International Development whether she supported the move by the United States Government for a compulsory
23 Nov 2001 : Column: 494W
licence to negotiate a lower price for the anti-anthrax drug, Cipro, at the World Trade Organisation meeting. [16072]
Ms Hewitt: I have been asked to reply.
The negotiations between the United States Government and the manufacturers of Cipro were private matters for the parties involved. In this instance, the United States Government reached an agreement with the manufacturer of Cipro for a bulk supply of this anti-anthrax drug at reduced prices without resort to a compulsory licence.
Tony Worthington: To ask the Secretary of State for International Development in what circumstances she has supported developing countries seeking a compulsory licence to negotiate lower drug prices; and if she will make a statement on her policy in such circumstances. [16073]
Ms Hewitt: I have been asked to reply.
The trade-related aspects of intellectual property rights agreement makes clear that any WTO member can issue a compulsory licence in certain circumstances. An individual WTO member itself determines the grounds upon which such a licence would be granted.
The declaration agreed at Doha last week on TRIPS and public health commits the TRIPS Council to finding a solution by end 2002 as to how WTO Members with insufficient or no manufacturing capacities in the pharmaceutical sector might make effective use of compulsory licensing under the TRIPS agreement. The UK (as part of the EU) intends to play a constructive role in those negotiations.
Tony Worthington: To ask the Secretary of State for International Development if it is her policy that the TRIPS agreement should not impede developing countries from taking measures to protect their public health; and what assessment she has made of the obstacles to achieving this. [16069]
Ms Hewitt: I have been asked to reply.
The UK wholeheartedly supports the declaration on the TRIPS agreement and public health issued at the successful conclusion of the fourth ministerial meeting of the WTO at Doha, Qatar. The declaration makes it clear that the TRIPS agreement does not and should not prevent Members from taking measures to protect public health.
I am confident that this agreement will both allow developing countries better access to vital medicines in the fight against diseases like HIV/AIDS and TB, and protect the patent system that promotes research into the drugs of the future.
Tony Worthington: To ask the Secretary of State for International Development what her policy is on a moratorium on formal WTO disputes over TRIPS. [16071]
Ms Hewitt: I have been asked to reply.
In relation to TRIPS and public health the UK wholeheartedly supports the declaration issued at the successful conclusion of the fourth ministerial meeting of the WTO at Doha, Qatar. The declaration makes clear that the TRIPS Agreement does not and should not prevent
23 Nov 2001 : Column: 495W
Members from taking measures to protect public health. It also extends the deadline for implementation of the agreement for the least developed countries, in relation to pharmaceutical products, by 10 years to 2016. Taken together, along with the rest of the declaration, it is clear that there is no need for a formal moratorium.
I have placed a copy of the declaration in the Library of the House.
Next Section | Index | Home Page |